South Korea
· Delayed Price · Currency is KRW Access Bio Statistics
Total Valuation
Access Bio has a market cap or net worth of KRW 175.15 billion. The enterprise value is -121.76 billion.
| Market Cap | 175.15B |
| Enterprise Value | -121.76B |
Important Dates
The next estimated earnings date is Monday, March 17, 2025.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Access Bio has 33.81 million shares outstanding. The number of shares has decreased by -9.97% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 33.81M |
| Shares Change (YoY) | -9.97% |
| Shares Change (QoQ) | +25.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.18% |
| Float | 24.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.33 |
Financial Position
The company has a current ratio of 17.56, with a Debt / Equity ratio of 0.10.
| Current Ratio | 17.56 |
| Quick Ratio | 15.79 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.68 |
| Interest Coverage | -6.85 |
Financial Efficiency
Return on equity (ROE) is -2.44% and return on invested capital (ROIC) is -2.26%.
| Return on Equity (ROE) | -2.44% |
| Return on Assets (ROA) | -2.18% |
| Return on Capital (ROIC) | -2.26% |
| Revenue Per Employee | 1.18B |
| Profits Per Employee | -131.72M |
| Employee Count | 101 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -43.91% |
| 50-Day Moving Average | 5,756.20 |
| 200-Day Moving Average | 6,703.95 |
| Relative Strength Index (RSI) | 39.40 |
| Average Volume (20 Days) | 96,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Access Bio had revenue of KRW 118.85 billion and -13.30 billion in losses. Loss per share was -411.36.
| Revenue | 118.85B |
| Gross Profit | 30.90B |
| Operating Income | -24.61B |
| Pretax Income | -14.30B |
| Net Income | -13.30B |
| EBITDA | -7.33B |
| EBIT | -24.61B |
| Loss Per Share | -411.36 |
Balance Sheet
The company has 361.17 billion in cash and 61.98 billion in debt, giving a net cash position of 299.19 billion or 8,848.74 per share.
| Cash & Cash Equivalents | 361.17B |
| Total Debt | 61.98B |
| Net Cash | 299.19B |
| Net Cash Per Share | 8,848.74 |
| Equity (Book Value) | 604.28B |
| Book Value Per Share | 17,114.76 |
| Working Capital | 388.73B |
Cash Flow
In the last 12 months, operating cash flow was -84.83 billion and capital expenditures -6.71 billion, giving a free cash flow of -91.54 billion.
| Operating Cash Flow | -84.83B |
| Capital Expenditures | -6.71B |
| Free Cash Flow | -91.54B |
| FCF Per Share | -2,707.34 |
Margins
Gross margin is 26.00%, with operating and profit margins of -20.71% and -11.19%.
| Gross Margin | 26.00% |
| Operating Margin | -20.71% |
| Pretax Margin | -12.03% |
| Profit Margin | -11.19% |
| EBITDA Margin | -6.17% |
| EBIT Margin | -20.71% |
| FCF Margin | n/a |
Dividends & Yields
Access Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.97% |
| Shareholder Yield | 9.97% |
| Earnings Yield | -7.94% |
| FCF Yield | -52.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Access Bio has an Altman Z-Score of 3.89.
| Altman Z-Score | 3.89 |
| Piotroski F-Score | n/a |